Automated Blood Processing Equipment Market Trends

  • Report ID: 5922
  • Published Date: Nov 08, 2024
  • Report Format: PDF, PPT

Automated Blood Processing Equipment Market Trends

Growth Drivers

  • Increase in Chronic Diseases Globally - The majority of the global disease burden is accounted for by the rise in the burden of chronic illness over time. While the epidemiology of chronic disease burden differs by nation, most industrialized and developing nations have significant chronic disease burden rates. The same procedures primary care physicians use to test for depression or diabetes should also be used to screen for sleep issues. Access to reasonably priced, successful treatments for sleep problems, such as cognitive behavioral therapy, should be made possible by governments and healthcare systems. This is particularly crucial for blacks, American Indians, Alaska Natives, and others with lower incomes. Studies reveal that racial or ethnic minorities experience more sleep disturbances and specific sleep disorders than other racial or ethnic groups, yet they also receive fewer diagnoses and less treatment.
  • Increasing Campaign for Blood Donation Programs - All of Lifeblood's donors are urged to become social media celebrities.  Their website provides a four-step strategy to help donors spread the word about the need for 33,000 contributions each week to help meet the need for products made from blood and plasma. The New York Blood Center is aware of the critical role that community influencers play in bringing awareness to the ongoing need for blood. To guarantee the success of their influencers, they have developed an online resource that offers social media postings, photos, videos, brochures, and more. Physicians worldwide utilize blood supplies to treat a wide range of illnesses, including cancer, anemia, heart, kidney, and stomach disorders, traumatic injuries sustained in emergencies, natural disasters, and accidents, among others.
  • Increasing Prevalence of Patients Experiencing Chemotherapy - It is predicted that there will be 26 million new cases of cancer in 2040, the majority of which will occur in low- and middle-income nations. In 2018, there were about 17 million new cases of cancer. The study projects that by 2040, two-thirds (67%) of patients in need of chemotherapy will reside in these nations, as will 75% of the 5.2 million more patients who would require the treatment by then.

Challenges

  • Higher Rate of Costs of Automated Blood Collection Devices- Blood collection tubes are made of sterile plastic and have a colored rubber stopper that seals the tube to produce a vacuum that makes it simpler to remove a certain volume of liquid. Serum separator tubes are most frequently used for venipuncture blood sample collection. Additives intended to stabilize and preserve the specimen before analytical testing may be present in some tubes. Rubber stoppers, which are safety-engineered closures, come in a range of draw volumes, labeling options, and stopper colors for tubes.
  • Blood cultures (BCs), still regarded as the gold standard for pathogen identification and susceptibility profile assessment, are used to detect pathogens, bacteria, or fungi responsible for BSI diagnosis. The proper collection and prompt delivery of BCs have a significant impact on the diagnostic yield. Additionally, safety during BC sampling must be addressed with the right protocols and by involving personnel who have received specific training.
  • Lack of Knowledge in People
  • Increase in Pollution

Automated Blood Processing Equipment Market: Key Insights

Base Year

2024

Forecast Year

2025-2037

CAGR

∼6.8%

Base Year Market Size (2024)

USD 55.74 billion

Forecast Year Market Size (2025-2037)

USD 131.1 billion

Regional Scope

  • North America (North America, Canada, Mexico)
  • Europe (Germany, Spain, UK, France, Italy, Russia, Others)
  • Asia Pacific (Japan, China, India, Australia, Others)
  • Middle East and Africa (South Africa, UAE, Others)
  • Latin America (Brazil, Argentina, Others)
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 5922
  • Published Date: Nov 08, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of automated blood processing equipment is assessed at USD 58.77 billion.

The automated blood processing equipment market size was valued at USD 55.74 billion in 2024 and is expected to reach USD 131.1 billion by 2037, registering around 6.8% CAGR during the forecast period i.e., between 2025-2037. The increasing number of road traffic accidents across the world will drive the market growth.

North America industry is poised to account for largest revenue share of 35% by 2037, owing to increasing advancement in technology for blood processing in this region.

The major players in the market include Nipro Medical Corporation, Business PlanningMain Product OfferingsFinancial ExecutionMain Performance IndicatorsBD, Terumo BCT Inc., Fresenius KABI AG, Grifols S.A., Greiner AG, Quest Diagnostics Incorporated, Macopharma, SARSTEDT AG & Co. KG, ICU Medical, Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample